NCT03787186View on ClinicalTrials.gov

A Study in Healthy Male Volunteers to Look at How the Test Medicine GLPG1690 is Taken up by the Body When Given by Mouth and Into a Vein as an Injection

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 9, 2018

Primary Completion Date

January 17, 2019

Study Completion Date

January 17, 2019

Conditions
Healthy
Interventions
DRUG

GLPG1690 film-coated tablets

a single oral dose of GLPG1690

DRUG

[14C]-GLPG1690 solution for infusion

a 15-minute IV infusion \[14C\]-GLPG1690

DRUG

[14C]-GLPG1690 capsules

single oral dose of \[14C\]-GLPG1690

Trial Locations (1)

NG11 6JS

Quotient Sciences Limited, Ruddington

Sponsors

Lead Sponsor

Galapagos NV
All Listed Sponsors
lead

Galapagos NV

INDUSTRY

NCT03787186 - A Study in Healthy Male Volunteers to Look at How the Test Medicine GLPG1690 is Taken up by the Body When Given by Mouth and Into a Vein as an Injection | Biotech Hunter | Biotech Hunter